✦ LIBER ✦

Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators

✍ Scribed by F. Awouters; C. J. E. Niemegeers; J. Van den Berk; J. M. Van Nueten; F. M. Lenaerts; M. Borgers; K. H. L. Schellekens; A. Broeckaert; J. De Cree; P. A. J. Janssen

Book ID: 112655475
Publisher: Springer
Year: 1977
Tongue: English
Weight: 372 KB
Volume: 33
Category: Article
ISSN: 1420-682X
DOI: 10.1007/bf01934056

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD28 and secretory immunoglobulin A-depe

CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate

✍ G. Woerly; V. Decot; S. Loiseau; M. Loyens; J. Chihara; N. Ono; M. Capron 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Clinical pharmacology of the new beta-ad

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 11. Effects of oral labetalol in patients with both angina pectoris and hypertension: a preliminary experience

✍ Stanley Halprin; William Frishman; Marc Kirschner; Joel Strom 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 890 KB

A quantitative approach to probe the dep

A quantitative approach to probe the dependence and correlation of food-effect with aqueous solubility, dose/solubility ratio, and partition coefficient (Log P) for orally active drugs administered as immediate-release formulations

✍ Brahma N. Singh 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 217 KB 👁 1 views